These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26899975)

  • 1. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
    Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.
    Huang Z; Chen X; Fu H; Wen X; Ma C; Zhang J; Wu C; Huang Y; Pan X; Wu C
    J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week subchronic intramuscular toxicity study of risperidone-loaded microspheres in rats.
    Zhang J; Ye L; Wang W; Du G; Yu X; Zhu X; Dong Q; Cen X; Guan X; Fu F; Tian J
    Hum Exp Toxicol; 2015 Feb; 34(2):205-23. PubMed ID: 24812153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
    Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres.
    Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyester-based microparticles of different hydrophobicity: the patterns of lipophilic drug entrapment and release.
    Korzhikov V; Averianov I; Litvinchuk E; Tennikova TB
    J Microencapsul; 2016 May; 33(3):199-208. PubMed ID: 26888064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of near zero-order release PLGA-based microspheres of a novel antipsychotic.
    Zhao J; Wang L; Fan C; Yu K; Liu X; Zhao X; Wang D; Liu W; Su Z; Sun F; Li Y
    Int J Pharm; 2017 Jan; 516(1-2):32-38. PubMed ID: 27825865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.